Veterinary World

     Open access and peer reviewed journal  

ISSN (Online): 2231-0916


Home l Editorial board l Instructions for authors l Reviewer guideline l Open access policy l Archives l FAQ

Open Access

Copyright: The authors. This article is an open access article licensed under the terms of the Creative Commons Attribution License

( which permits unrestricted use, distribution and reproduction in any medium, provided the work is properly cited.

Research (Published online: 19-09-2015)

11. Validation of γ-radiation and ultraviolet as a new inactivators for foot and mouth disease virus in comparison with the traditional methods - Safy El din Mahdy, Amr Ismail Hassanin, Wael Mossad Gamal El-Din, Ehab El-Sayed Ibrahim, and Hiam Mohamed Fakhry

Veterinary World, 8(9): 1088-1098



   doi: 10.14202/vetworld.2015.1088-1098


Safy El din Mahdy: Department of Foot and Mouth Disease, Veterinary Serum and Vaccine Research Institute, Abbasia, P. O. Box. 131, Cairo, Egypt;

Amr Ismail Hassanin: Department of Foot and Mouth Disease, Veterinary Serum and Vaccine Research Institute, Abbasia, P. O. Box. 131, Cairo, Egypt;

Wael Mossad Gamal El-Din: Department of Foot and Mouth Disease, Veterinary Serum and Vaccine Research Institute, Abbasia, P. O. Box. 131, Cairo, Egypt;

Ehab El-Sayed Ibrahim: Department of Foot and Mouth Disease, Veterinary Serum and Vaccine Research Institute, Abbasia, P. O. Box. 131, Cairo, Egypt;

Hiam Mohamed Fakhry: Department of Foot and Mouth Disease, Veterinary Serum and Vaccine Research Institute, Abbasia, P. O. Box. 131, Cairo, Egypt;


Received: 07-05-2015, Revised: 09-08-2015, Accepted: 20-08-2015, Published online: 19-09-2015


Corresponding author: Ehab El-Sayed Ibrahim, e-mail:

Citation: Mahdi SE, Hassanian AI, El-Din WMG, Ibrahim EE, Fakhry HM (2015) Validation of γ-radiation and ultraviolet as a new inactivators for foot and mouth disease virus in comparison with the traditional methods, Veterinary World 8(9): 1088-1098.

Aim: The present work deals with different methods for foot and mouth disease virus (FMDV) inactivation for serotypes O/pan Asia, A/Iran05, and SAT-2/2012 by heat, gamma radiation, and ultraviolet (UV) in comparison with the traditional methods and their effects on the antigenicity of viruses for production of inactivated vaccines.

Materials and Methods: FMDV types O/pan Asia, A/Iran05, and SAT-2/2012 were propagated in baby hamster kidney 21 (BHK21) and titrated then divided into five parts; the first part inactivated with heat, the second part inactivated with gamma radiation, the third part inactivated with UV light, the fourth part inactivated with binary ethylamine, and the last part inactivated with combination of binary ethylamine and formaldehyde (BEI+FA). Evaluate the method of inactivation via inoculation in BHK21, inoculation in suckling baby mice and complement fixation test then formulate vaccine using different methods of inactivation then applying the quality control tests to evaluate each formulated vaccine.

Results: The effect of heat, gamma radiation, and UV on the ability of replication of FMDV "O/pan Asia, A/Iran05, and SAT-2/2012" was determined through BHK cell line passage. Each of the 9 virus aliquots titer 108 TCID50 (3 for each strain) were exposed to 37, 57, and 77°C for 15, 30, and 45 min. Similarly, another 15 aliquots (5 for each strain) contain 1 mm depth of the exposed samples in petri-dish was exposed to UV light (252.7 nm wavelength: One foot distance) for 15, 30, 45, 60, and 65 min. Different doses of gamma radiation (10, 20, 25, 30, 35, 40, 45, 50, 55, and 60 KGy) were applied in a dose rate 0.551 Gy/s for each strain and repeated 6 times for each dose. FMDV (O/pan Asia, A/Iran05, and SAT-2/2012) were inactivated when exposed to heat ≥57°C for 15 min. The UV inactivation of FMDV (O/pan Asia and SAT-2) was obtained within 60 min and 65 min for type A/Iran05. The ideal dose for inactivation of FMDV (O/pan Asia, A/Iran05, and SAT-2/2012) with gamma radiation were 55-60 and 45 kGy, respectively. Inactivation of FMDV with binary was 20, 24 and 16 hr for O/pan Asia, A/Iran05, and SAT-2/2012, respectively while inactivation by (BEI+FA) was determined after 18, 19 and 11 hr for O/pan-Asia, A/Iran 05, and SAT-2/2012, respectively. The antigenicity of control virus before inactivation was 1/32, it was not changed after inactivation in case of gamma radiation and (BEI+FA) and slightly decrease to 1/16 in case of binary and declined to 1/2, 1/4 in case of heat and UV inactivation, respectively. The immune response induced by inactivated FMD vaccines by gamma radiation and (BEI+FA) lasted to 9 months post-vaccination, while the binary only still up to 8 months post-vaccination but heat and UV-inactivated vaccines were not effective.
Conclusion: Gamma radiation could be considered a good new inactivator inducing the same results of inactivated vaccine by binary with formaldehyde (BEI+FA).
Keywords: A/Iran05 and SAT-2/2012, binary, combination (BEI+FA), enzyme linked immunosorbent assay (ELISA), foot and mouth disease virus, gamma radiation, heat, inactivation, ISA201, O/pan Asia, ultraviolet light, vaccine formulation, serum neutralization test.

1. Paton, D.J., Sumption, K.J. and Charleston, B. (2009) Options for control of foot and-mouth disease: Knowledge, capability and policy. Philos. Trans. R. Soc. B., 364(1530): 2657-2667.
PMid:19687036 PMCid:PMC2865093
2. FAO. (2012) Foot-and-mouth disease caused by serotype SAT2 in Egypt and Libya: A regional concern for animal health in North Africa and the Middle East "EMPRES WATCH, vol.25, March 2012, Rome.
3. Depa, P.M., Dimri, U., Sharma, M.C. and Tiwari, R. (2012) Update on epidemiology and control of foot and mouth disease – A menace to international trade and global animal enterprise. Vet. World, 5(11): 694-704.
4. Barteling, S.J. and Cassim, N.I. (2004) Very fast (and safe) inactivation of FMD virus and entero viruses by a combination of binary ethylenimine and formaldehyde. Dev. Biol. (Basel), 119, 449-455.
5. Declarq, K., Goris, N., Barnett, P.V. and MacKay, D. (2008) FMD vaccines: Reflections on quality aspects for applicability in European disease control policy. Transbound. Emerg. Dis., 55(1): 46-56.
6. Barteling, S.J. and Woortmeijer, R. (2002) Formaldehyde inactivation of foot-and-mouth disease virus. Conditions for the preparation of safe vaccine. Arch. Virol., 80: 103.
7. Wilton, T., Dunn, G., Eastwood, D., Minor, P.D. and Martin, J. (2014) effect of formaldehyde inactivation on poliovirus. J. Virol., 88(20): 11955-19564.
PMid:25100844 PMCid:PMC4178759
8. Martín-Acebes, M.A., Vázquez Calvo, Á., González Magaldi, M. and Sobrino, F. (2011) Foot-and-mouth disease virus particles inactivated with binary ethylenimine are efficiently internalized into cultured cells. Vaccine, 29(52): 9655-9562.
9. Wijnker, J.J., Haas, B. and Berends, B.R. (2012) Inactivation of foot-and-mouth disease virus in various bovine tissues used for the production of natural sausage casings. Int. J. Food Microbiol., 153: 237-240.
10. Maves, R.C., Ore, R.M., Porter, K.R. and Kochel, T.J. (2011) Immunogenicity and protective effi cacy of a psoralen-inactivated dengue-1 virus vaccine candidate in Aotus nancymaae monkeys. Vaccine, 29(15): 2691-2696.
11. Amanna, I.J., Raue, H.P. and Slifka, M.K. (2012) Development of a new hydrogen peroxide-based vaccine platform. Nat. Med., 18(6): 974-979.
PMid:22635006 PMCid:PMC3506259
12. Ghori, M.T., Muhammad, K. and Rabbani, M. (2011) Physical factors affecting in vitro replication of foot and mouth disease virus (Serotype "O"). Pak. Vet. J., 31(4): 313-316.
13. Nims, R.W. and Plavsic, M. (2012) Polyo mavirus inactivation – A review. Biologicals, 41(2): 63-70.
14. Seo, K., Lee, J.E., Lim, M.Y. and Ko, G. (2012) Effect of temperature, pH, and NaCl on the inactivation kinetics of murine norovirus. J. Food Prot., 75(3): 533-540.
15. De Roda Husman, A.M., Bijkerk, P., Lodder, W., van den Berg, H., Pribil, W., Cabaj, A., Gehringer, P., Sommer, R. and Duizer, E. (2004) Calicivirus inactivation by nonionizing (253.7-nanometer - wavelength [UV]) and ionizing (gamma) radiation. Appl. Environ. Microbiol., 70: 5089-5093.
PMid:15345386 PMCid:PMC520909
16. Nuanualsuwan, S., Mariam, T., Himathongkham, S. and Cliver, D.O. (2002) Ultraviolet inactivation of feline calicivirus, human enteric viruses and coliphages. Photochem. Photobiol., 76: 406-410.
17. Lombardo, J.H. and Smolko, E. (1990) A biotechnological project with a gamma radiation source of 100,000 ci. Radiat. Phys. Chem., 35(4-6): 585-589.
18. Motamedi Sedeh, F., Khorasani, A., Shafaee, K., Salehizadeh, M., Majd, F. and Fatolahi, H. (2008) Study of gamma irradiation to preparation of foot and mouth disease inactivated vaccine. Proceedings of the Fourth International Iran & Russia Conference. p924-927.
19. Martin, S.S., Bakken, R.R., Lind, C.M., Garcia, P., Jenkins, E., Glass, P.J., Parker, M.D., Hart, M.K. and Fine, D.L. (2010) Comparison of the immunological responses and efficacy of gamma-irradiated V3526 vaccine formulations against subcutaneous and aerosol challenge with Venezuelan equine encephalitis virus subtype IAB. Vaccine, 28(4): 1031-1040.
PMid:19914193 PMCid:PMC2815090
20. Alsharifi, M. and Mullbacher, A. (2010) The gamma-irradiated influenza vaccine and the prospect of producing safe vaccines in general. Immunol. Cell Biol., 88(2): 103-104.
21. Nuanualsuwan, S., Thongtha, P., Kamolsiripichaiporn, S. and Subharat, S. (2008) UV inactivation and model of UV inactivation of foot and mouth disease viruses in suspension. Int. J. Food Microbiol., 127: 84-90.
22. Brown, F. (1968) Have peptides as future as FMD vaccines. 4th Meeting of the European Group of Molecular Biology of Picornaviruses, September. p1-7.
23. Brown, F. and Newmann, J.F.E. (1963) In vitro measurement of potency of inactivated FMDV. Vaccines. J. Hyg. Comb., 61: 345-351.
24. Brown, F., Hylslop, N.S.G., Crick, J. and Morrow, A.W. (1963) The use of acetyl ethylenimine in the production of inactivated foot-and-mouth disease vaccines. J. Hyg. Camb., 61: 337-344.
PMid:14066590 PMCid:PMC2134528
25. Bahneman, H.G. (1975) Binary ethyleneimine as an inactivator for FMDV and its application for vaccine production. Arch. Virol., 47: 47-56.
26. Bahneman, H.G. (1990) Inactivation of viral antigens for vaccine preparation with particular refrence to the application of binary ethylenimine. Vaccine, 8: 299-304.
27. Longjam, N., Deb, R., Sarmah, A.K., Tayo, T., Awachat, V.B. and Saxena, V.K. (2011) A brief review on diagnosis of foot – and – mouth disease of livestock: Conventional to molecular tools. Vet. Med. Int., 2011: Article ID: 905768, 17.
28. Barteling, S.J. and Vreeswijk, J. (1991) Developments in foot and mouth disease vaccines. Vaccine, 9: 75-87.
29. Donn, A., Castagnaro, M. and Donaldson, A.I. (1995) Ultra structural and replicative of foot and mouth disease virus in persistently infected BHK-21 cells. Arch. Virol., 140: 13-25.
30. Reed, L.J. and Muench, H. (1938) A simple method of estimating 50% end points. Am. J. Hyg., 27: 493-497.
31. Farid, A., Reda, I., Moussa, A.A.M. and Daoud, A. (1979). The effect of different chemical inactivator on the antigenicity and infectivity of FMD virus. J. Egypt. Vet. Med. Assoc., 39(I): 45-55.
32. Girard, H.C., Bayramogh, O., Erol, N. and Burgut, A. (1977) Inactivation of O1 FMD virus by binary ethyleneimine (BEI). Bull. Off. Int. Epiz., 87(3-4): 201-217.
33. OIE. (2012) FMD. In: Manual of Standard for Diagnostic Test and Vaccine. Ch. 2.1.5. OIE, Paris. p77-92.
34. Health Protection Agency. (2009) Complement fixation tests. Standards Unit, Department for Evaluations, Standards and Training, p1.
35. Ferreira, M.E.V. (1976) Prubade microneutralization poraestudies de anticueropos de la fibre aftosa. 13th Centropanamericano Fibre Aftosa, (21/22) 17-24.
36. Hamblin, C., Barnett, I.T.R. and Hedger, R.S. (1986). A new enzymelinked immunosorbent assay (ELISA) for the detectionof antibodies against foot and mouth disease virus. 1. Development and method of ELISA. J. Immunol. Methods., 93: 115-121.
37. Razdan, R., Sen, A.K., Rao, B.V. and Suryanarayana, V.V. (1996) Stability of foot-and-mouth disease virus, its genome and proteins at 37°C. Acta Virol., 40: 9-14.
38. Turner, C., Williams, S.M. and Cumby, T.R. (2000) The inactivation of foot and mouth disease, Aujeszky'sdisease and classical swine fever viruses in pig slurry. J. Appl. Microbiol., 89: 760-767.
39. Kamolsiripichaiporn, S., Subharat, S., Udon, R., Thongtha, P. and Nuanualsuwan, S. (2007) Thermal inactivation of foot-and-mouth disease viruses in suspension. Appl. Environ. Microbiol., 73: 7177-7184.
PMid:17660312 PMCid:PMC2168231
40. Kariwa, H., Fujii, N, and Takashima, I. (2006) Inactivation of SARS coronavirus by means of povidone-iodine, physical conditions and chemical reagents. Dermatology, 1: 119-123.
41. Nettleton, P.F., Davies, M.J. and Rweyemamu, M.M. (1982) Guanidine and heat sensitivity of foot and mouth disease virus (FMDV) strains. J. Hyg., 89: 129-138.
42. Rabia, S.A., Fibach, E., Kotler, M. and Gatt, S. (1990) Inactivation of vesicular stomatitis virus by photosensitization following incubation with a pyrene fatty acid. FEBS Lett., 270: 9-10.
43. Hazem, A. (2002) Effects of temperatures, pH-values,ultra-violet light, ethanol and chloroform on the growth of isolated thermophilic Bacillus phages. New Microbial, 25: 469-476.
44. Motamedi Sedehl, F., Khorasani, A., Shafaee, K., Fatolahi, H. and Arbabi, K. (2008) Preparation of FMD type A87/IRN inactivated vaccine by gamma irradiation and the immune response on guinea pig. Indian J. Microbiol., 48: 326-330.
PMid:23100729 PMCid:PMC3476770
45. Ali, S.M., Abd El-Aty, M.M., Elnakashly, S.A. and El-Kilany, A.S. (2009) Inactivation of FMDV (Type O and A) by using a combination of binary ethyleneamine and formaldehyde. 3rd Science Congress Faculty of Kafr ElSheik, p962-973.
46. Aarthi, D., Ananda Rao, K., Robinson, R. and Srinivasan, V.A. (2004) Validation of Binary Ethyleneimine (BEI) used as aninactivant for tissue culture vaccine. Biologicals, 32(3): 153-156.
47. Ismail, A.H., El-Mahdy, S.A., Mossad, W.G., Abd El-Krim, A.S., Abou, El-Yazid, M. and Ali, S.M. (2013) Optimization of the inactivation process of FMD virus serotype SAT-2 by Binary Ethyleneimine (BEI). J. Vet. Adv., 3(3): 117-124.
48. Soliman, E.M., Mahdy, S.E., Mossad, W.G., Hassanin, A.I. and El-Sayed, E.I. (2013) Effect of different inactivators on the efficacy of Egyptian foot and mouth disease SAT2 vaccine. J. Anim. Sci. Adv., 3(8): 388-395.
49. Ljungman, P. (2012) Vaccination of immunocompromised patients. Clin. Microbiol. Infect., 18 Suppl 5: 93-99.